Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Calcium. 2013 Mar;23(3):401-8. doi: CliCa1303401408.

[Assessment of the treatment of glucocorticoid-induced osteoporosis].

[Article in Japanese]

Author information

1
Toyokawa City Hospital, Toyokawa, Aichi, Japan.

Abstract

Glucocorticoid-induced osteoporosis (GIOP) is known as a serious adverse side effect during long-term glucocorticoid treatment. Several clinical guidelines are available to whom and how we should start to treat GIOP. However, the assessment of the treatment of GIOP is still controversial. Accumulating evidences suggest us that both bone mineral density and bone turn over markers could reflect the effect of some pharmacological agents on bone metabolism. However, further studies would be required for precise assessment of the efficacy of drugs on fracture prevention in GIOP.

PMID:
23445894
DOI:
CliCa1303401408
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center